John M. Hoffmann

Array ( [id] => 8126735 [patent_doc_number] => 20120087912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'TREATMENT METHODS USING DKK-1 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/323566 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 38922 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20120087912.pdf [firstpage_image] =>[orig_patent_app_number] => 13323566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264722 [patent_doc_number] => 20120164150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Monoclonal Antibodies Against Activated Protein C' [patent_app_type] => utility [patent_app_number] => 13/306301 [patent_app_country] => US [patent_app_date] => 2011-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11612 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818510 [patent_doc_number] => 20120065130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'METHODS FOR TREATING CONGESTIVE HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 13/292193 [patent_app_country] => US [patent_app_date] => 2011-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14431 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065130.pdf [firstpage_image] =>[orig_patent_app_number] => 13292193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184121 [patent_doc_number] => 20120114653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'ANTIBODY THERAPY FOR TREATMENT OF DISEASES ASSOCIATED WITH GLUTEN INTOLERANCE' [patent_app_type] => utility [patent_app_number] => 13/290335 [patent_app_country] => US [patent_app_date] => 2011-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6232 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114653.pdf [firstpage_image] =>[orig_patent_app_number] => 13290335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12927976 [patent_doc_number] => 09828437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-28 [patent_title] => MMP8 inactivating antigen binding proteins [patent_app_type] => utility [patent_app_number] => 13/883444 [patent_app_country] => US [patent_app_date] => 2011-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 3209 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976045 [patent_doc_number] => 20130209475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'DKK1 ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/878619 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 42347 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8405950 [patent_doc_number] => 20120238013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'FUSION PARTNER FOR PRODUCTION OF MONOCLONAL RABBIT ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/274946 [patent_app_country] => US [patent_app_date] => 2011-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7215 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13274946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754615 [patent_doc_number] => 20120027765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 13/252016 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 152 [patent_no_of_words] => 72986 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027765.pdf [firstpage_image] =>[orig_patent_app_number] => 13252016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10001468 [patent_doc_number] => 09045547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 13/251909 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 163 [patent_no_of_words] => 73085 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13251909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152492 [patent_doc_number] => 08168762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 13/251955 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 163 [patent_no_of_words] => 73122 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168762.pdf [firstpage_image] =>[orig_patent_app_number] => 13251955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056457 [patent_doc_number] => 20120077964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'ANTAGONISTS OF PCSK9' [patent_app_type] => utility [patent_app_number] => 13/246219 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20958 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077964.pdf [firstpage_image] =>[orig_patent_app_number] => 13246219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577904 [patent_doc_number] => 08344114 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Antagonists of PCSK9' [patent_app_type] => utility [patent_app_number] => 13/242744 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20971 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13242744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054111 [patent_doc_number] => 20120076799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'ANTAGONISTS OF PCSK9' [patent_app_type] => utility [patent_app_number] => 13/242809 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20959 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076799.pdf [firstpage_image] =>[orig_patent_app_number] => 13242809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094141 [patent_doc_number] => 20120082680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'ANTAGONISTS OF PCSK9' [patent_app_type] => utility [patent_app_number] => 13/242831 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20961 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082680.pdf [firstpage_image] =>[orig_patent_app_number] => 13242831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10076309 [patent_doc_number] => 09114144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Kallikrein-inhibitor therapies' [patent_app_type] => utility [patent_app_number] => 13/228300 [patent_app_country] => US [patent_app_date] => 2011-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20212 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13228300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742259 [patent_doc_number] => 20120020962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'METHOD OF DEPLETING REGULATORY T CELL' [patent_app_type] => utility [patent_app_number] => 13/225811 [patent_app_country] => US [patent_app_date] => 2011-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17897 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020962.pdf [firstpage_image] =>[orig_patent_app_number] => 13225811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895088 [patent_doc_number] => 20150050287 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-02-19 [patent_title] => 'ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/820278 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 39852 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895088 [patent_doc_number] => 20150050287 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-02-19 [patent_title] => 'ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/820278 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 39852 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650800 [patent_doc_number] => 20110300069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => ' Methods of Using Labeled Ligands Having Human CD4 Specificity' [patent_app_type] => utility [patent_app_number] => 13/211414 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8565 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300069.pdf [firstpage_image] =>[orig_patent_app_number] => 13211414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7652067 [patent_doc_number] => 20110301336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'ANTIBODY PRODUCED USING OSTRICH AND METHOD FOR PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/210512 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6603 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301336.pdf [firstpage_image] =>[orig_patent_app_number] => 13210512 [rel_patent_id] =>[rel_patent_doc_number] =>)